Key Takeaways Pembina reported Q1 adjusted EBITDA of C$1.2B, up 12%, and raised its dividend by 3% to C$0.71. PBA secured long-term take-or-pay deals boosting volumes on its pipelines and processing systems. Growth projects like Cedar LNG are advancing, but delays and capital intensity could affect returns.Pembina Pipeline Corporation (PBA) , headquartered in Calgary, Alberta, is a major force in North America's energy infrastructure sector. The company manages an extensive system of pipelines, gas proces ...

Key Takeaways AREC and ReElement extended their antimony refining agreement to a 10-year term with auto-renewals. The revised deal will generate more than $29M annually from purified antimony for defense and commercial use. ReElement begins processing 500 metric tons/month of stibnite ore, with capacity set to grow with demand.American Resources Corporation (AREC) , and its portfolio company, ReElement Technologies Corporation, recently announced an expansion of their existing antimony tolling agreement. ...

Group 1 - SAIC reported quarterly earnings of $1.92 per share, missing the Zacks Consensus Estimate of $2.14 per share, representing an earnings surprise of -10.28% [1] - The company posted revenues of $1.88 billion for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 0.71%, compared to year-ago revenues of $1.85 billion [2] - Over the last four quarters, SAIC has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2 - The stock's immediate price movement will depend on management's commentary on the earnings call and the sustainability of earnings expectations [3][4] - SAIC shares have increased by approximately 3.4% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the coming quarter is $2.21 on $1.86 billion in revenues, and for the current fiscal year, it is $9.19 on $7.67 billion in revenues [7] Group 3 - The Computers - IT Services industry, to which SAIC belongs, is currently in the top 38% of Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for SAIC is currently mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market [6]

Mt Olive, New Jersey, USA, June 02, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (OTCQB: VISL) , a global technology leader in the capture, delivery, and management of high-quality live video and associated data across defense, public safety, and broadcast sectors today announced the appointment of William J. Bender, USAF, Lt. Gen. (Ret.) to its Board of Directors, effective June 1, 2025. Lt. Gen. Bender brings to Vislink a distinguished record of leadership in the technology, cybersecurity, and defe ...

The conference will focus on how the rapid evolution of technology is paving the way for disruption across all industries, including healthcare, drones, consumer IoT, business solutions, gaming & entertainment, and more. Key topics will include an exploration of how emerging growth companies are expanding their use of quantum computing and artificial intelligence (AI) to position themselves for the future. Maxim Group's senior analysts will facilitate engaging dialogues with CEOs and key management of diver ...

Core Viewpoint - CERo Therapeutics Holdings, Inc. has significantly expanded its intellectual property portfolio with the granting of multiple patents, enhancing its position in the immunotherapy market focused on engineered T cell therapeutics [1][5][6]. Patent Developments - The USPTO granted U.S. Patent No. 12,291,557 for the chimeric TIM4 receptor, which protects design aspects of the lead compound CER-1236 [2]. - The European Patent Office allowed European Patent Application No. 1882166.7, covering a chimeric engulfment receptor that further protects CER-1236's design aspects already granted in the U.S., Japan, and China [3]. - U.S. Patent No. 12,303,551 was granted for cellular immunotherapy compositions, covering combination therapies involving CER-1236, which may enhance treatment options for cancer [4]. Intellectual Property Portfolio - CERo's intellectual property now includes a total of 18 issued patents and allowed patent applications internationally, with 9 total patent families providing protection until 2042 in the United States [5][6]. Company Strategy and Future Plans - The CEO of CERo emphasized the importance of expanding the intellectual property portfolio to ensure market success and highlighted the novelty of the CER-T technology [6]. - The company anticipates updates on clinical trial progress for acute myeloid leukemia (AML) and plans to initiate human trials for ovarian and non-small cell lung cancers [6][7].

Ticket holders on Governors Island, New York gather to watch SailGP races, Season 4, New York, Sunday 23rd June 2024.Katelyn Mulcahy for SailGPFans watching the New York races for international sailing league SailGP this weekend will have another reason to root for their favorite team.SailGP is working with gaming companies DraftKings in the United States and Bet365 internationally to let fans place bets on races, starting at the Mubadala New York Sail Grand Prix on June 7 and 8."It's a sport that's natural ...

Vera Therapeutics, Inc. VERA saw its share price surge over 65% during the pre-market trading session on Monday after the company released ORIGIN Phase 3 trial data.Participants treated with atacicept for immunoglobulin A nephropathy (IgAN) achieved a 46% reduction from baseline in proteinuria as measured by 24-hour urine protein-to-creatinine ratio (UPCR), with a statistically significant and clinically meaningful 42% reduction in UPCR compared to placebo (p<0.0001) at week 36.Also Read: Kidney Disease-Foc ...

ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that Azimut Exploration Inc. has announced additional positive assays from the Perseus Nickel Zone discovered in 2024 adjoining to the southeast of Globex’s Tyrone Property ...

Key Takeaways CVX lost access to high-margin Venezuelan output after its U.S. license expired on May 27, 2025. ExxonMobil is legally contesting CVX's $53B Hess deal, casting doubt on key growth plans. CVX's 2025 EPS estimate has fallen 34% in 60 days, pointing to weakening investor confidence.Chevron Corporation (CVX) has seen its stock drop roughly 16% over the past six months, falling behind both the S&P 500 and large-cap energy peers like ExxonMobil (XOM) . For a company known for its scale, dividend r ...